INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

An expert overview of the literature, useful as background reading.

1,981 studies · page 32 of 83

2015 / Review

A low-AGE diet reduces systemic AGEs, oxidative stress, and inflammatory markers in chronic kidney disease patients.

This review evaluates clinical evidence on dietary advanced glycation end products (AGEs) in chronic diseases, particularly chronic kidney disease (CKD). Clinical trials over the past decade show that an AGE-restricted diet reduces systemic AGE levels along with markers of oxidative stress and inflammation. These effects have been observed in CKD patients before and after starting dialysis, with or without coexisting diabetes. Reducing dietary AGEs through simple changes in culinary techniques is described as a feasible, safe, and easily applicable intervention.

Uribarri J, He JC Nephron, 2015. PMID 25871778

2015 / Literature review

A review of clinical literature found that ginger reduced nausea and vomiting across various clinical settings, likely via 5-HT3 receptor antagonism.

This review identified nine studies and seven reviews evaluating ginger for morning sickness, postoperative nausea and vomiting, chemotherapy-induced, and antiretroviral-induced nausea and vomiting. All identified studies reported that ginger provided a significant reduction in nausea and vomiting, though the clinical relevance of some studies was noted as less certain. Recent evidence also supported 5-HT3 receptor antagonism as a potential mechanism of action. The authors noted literature limitations including poor control or blinding, lack of standardized extracts, and limited sample sizes.

Marx W, Kiss N, Isenring L Curr Opin Support Palliat Care, 2015. PMID 25872115

2015 / Narrative review

Newer weight management medications aid weight loss and maintenance, with varying positive and potentially negative cardiometabolic effects.

Since the 1980s, obesity prevalence has nearly doubled globally, with treatments including lifestyle modification, medications, and surgery. This review discusses the mechanisms and cardiometabolic implications of newly approved next-generation weight management medications. These medications demonstrate efficacy in initial weight management and long-term maintenance, while showing varying effects on diabetes and cardiovascular risks.

Wharton S, Serodio KJ Curr Cardiol Rep, 2015. PMID 25894803

2015 / Expert workshop consensus summary / narrative review

An expert consensus identified dietary restriction mimetics and targeted drugs as promising strategies to test for extending human healthspan.

An expert workshop evaluated potential interventions to slow aging and increase healthy lifespan in humans. The panel agreed that evidence suggests aging interventions can delay and prevent chronic disease onset. Participants selected a subset of promising strategies for human testing: dietary interventions mimicking chronic restriction (such as periodic fasting mimicking diets and protein restriction), drugs inhibiting the growth hormone/IGF-I axis, drugs inhibiting the mTOR-S6K pathway, and drugs activating AMPK or specific sirtuins.

Longo VD, Antebi A, Bartke A, et al. Aging Cell, 2015. PMID 25902704

2015 / Narrative review / hypothesis

Authors hypothesize the ketogenic diet may facilitate fat loss without negatively affecting strength and power performance in sports.

The ketogenic diet is widely utilized for weight loss and occasionally for disease therapy. Weight control is frequently required in sports such as boxing, weightlifting, and wrestling, where the ketogenic diet is typically not considered. The authors hypothesize that the ketogenic diet could be applied to achieve fat loss without negatively impacting strength or power performance.

Paoli A, Bianco A, Grimaldi KA Exerc Sport Sci Rev, 2015. PMID 25906427

2015 / Narrative review of acute and long-term feeding studies and meta-analyses

Higher-protein diets of 1.2 to 1.6 g/kg/d improve weight management, appetite control, and cardiometabolic risk factors, especially with dietary compliance.

This review examines literature on mechanisms following acute protein consumption and clinical outcomes from long-term, higher-protein diets. Meta-analyses of shorter-term, tightly controlled feeding studies showed greater weight loss, fat mass loss, lean mass preservation, and reductions in triglycerides, blood pressure, and waist circumference with higher-protein diets. Acute trials confirmed modest satiety effects without affecting energy intake at the next meal, while longer-term studies yielded conflicting findings largely driven by dietary compliance. The evidence suggests diets containing 1.2 to 1.6 g protein · kg-1 · d-1 (with at least ~25-30 g/meal) provide improvements in appetite, weight management, and cardiometabolic factors.

Leidy HJ, Clifton PM, Astrup A, et al. Am J Clin Nutr, 2015. PMID 25926512

2015 / Historical review and narrative summary

Abdominal fat distribution is linked to increased insulin resistance and higher risk of type 2 diabetes and cardiovascular disease.

An early 1980s analysis of the metabolic profiles of 930 men and women showed that an abdominal distribution of fat for a given BMI is associated with increased insulin resistance and risk of type 2 diabetes and cardiovascular disease. This correlation has since been validated across multiple studies, establishing waist circumference as a diagnostic criterion for metabolic syndrome. Visceral fat represents one of several ectopic fat depots utilized when subcutaneous adipose tissue cannot accommodate excess fat due to limited expandability.

Shows an association, not proof of cause and effect.

Smith U J Clin Invest, 2015. PMID 25932676

2015 / Narrative review

Plant sterol and stanol intake is associated with an LDL cholesterol reduction of about 10% and an approximate doubling of circulating plant sterol concentrations.

This review evaluates arguments raised against the cardiovascular safety of plant sterols and stanols. Regular intake of functional foods containing plant sterols and stanols is associated with a decrease in low density lipoprotein cholesterol of about 10% and an increase in plasma plant sterol or stanol concentrations by about a factor of 2. Although lowering low density lipoprotein cholesterol benefits cardiovascular health, safety concerns have emerged regarding the concomitant increase in circulating plant sterols.

Silbernagel G, Baumgartner I, März W J AOAC Int, 2015. PMID 25942652

2015 / Narrative review

A review proposes a desirable serum 25-hydroxyvitamin D range of 20 to 40 ng/mL, achievable by daily intakes of 400-600 IU in children and 800 IU in adults.

This review examined sources of variation in circulating 25OHD levels, knowledge gaps, assay issues, and safety and efficacy data. Lifestyle and environmental factors account for up to 50% of variations in serum 25OHD, whereas genetic polymorphisms account for less than 5%. The authors propose a desirable 25OHD range of 20 to 40 ng/mL (50 to 100 nmol/L), noting that most groups can reach this target with daily intakes of 400 to 600 IU for children and 800 IU for adults. Daily intakes up to 1000 IU in pediatric groups and up to 2000 IU in adults are considered probably safe over long durations, though further validation is needed in children, pregnant women, and non-white populations.

Fuleihan Gel-H, Bouillon R, Clarke B, et al. J Bone Miner Res, 2015. PMID 25952470

2015 / Narrative review

Fiber supplements vary in efficacy, with only a minority possessing the physical traits necessary to drive clinically meaningful health benefits.

Approximately 90% of the US population fails to consume recommended fiber levels (25 g/d for women, 38 g/d for men), averaging only 15 g/d. Fiber supplements cannot be assumed to provide the same health benefits as intact dietary fiber from whole foods, as only a minority possess the physical characteristics that drive clinical efficacy. This review focuses on four primary fiber characteristics driving efficacy—solubility, degree/rate of fermentation, viscosity, and gel formation—as well as gel-dependent small-bowel mechanisms that influence outcomes such as cholesterol lowering and glycemic control.

McRorie JW Nutr Today, 2015. PMID 25972618

2015 / Review

Dietary modification focusing on specific nutrients, foods, and gut microbiota impacts may aid in preventing and managing atherosclerosis.

This narrative review examines the role of diet in the prevention and complementary clinical management of atherosclerosis. It discusses evidence and mechanisms for specific nutrients and foods, including fiber, plant sterols/stanols, niacin, taurine, olive oil, omega-3 fatty acids, antioxidants, minerals, methyl nutrients, and soy. It also highlights that intestinal microbiota dysbiosis associated with certain animal food sources can generate metabolites involved in atherosclerosis development.

Torres N, Guevara-Cruz M, Velázquez-Villegas LA, et al. Arch Med Res, 2015. PMID 26031780

2015 / Literature review

Evidence for the purported health benefits of human placentophagy remains inconclusive and requires further investigation.

A literature search from January 1950 to January 2014 examined empirical studies of human or animal consumption of human placentas, selecting 10 articles (four human, six animal). While a minority of women perceive placentophagy as reducing postpartum depression risk and enhancing recovery, experimental animal research on pain reduction has not been applied to humans. Evidence evaluating placenta consumption for facilitating uterine contraction, resuming normal cyclic estrogen cycles, and milk production remains inconclusive. The authors state that health benefits and risks require further investigation of raw, cooked, and encapsulated placenta contents.

Coyle CW, Hulse KE, Wisner KL, et al. Arch Womens Ment Health, 2015. PMID 26043976

2015 / Narrative review

A review indicates individuals with autism show significant intestinal microbiome differences, including increased clostridial species, compared to controls.

This review examined published literature evaluating the intestinal microbiota in individuals with autism. Studies reported significant differences in the microbiome of patients with autism compared with unaffected controls, including several reports of increased clostridial species. Alterations in the microbiome, potentially influenced by environmental factors, may contribute to autism via altered immune function and bacterial metabolites, and proposed interventions to modify microbial imbalances were discussed.

Shows an association, not proof of cause and effect.

Buie T Clin Ther, 2015. PMID 26046240

2015 / Narrative review / historical perspective

A review discusses regulatory improvements for dietary supplements under DSHEA across four areas: premarket approval, claims, manufacturing, and adverse events.

The Dietary Supplement Health and Education Act (DSHEA) of 1994 defines the FDA's authority over dietary supplements in the United States. With over half of the US population using supplements and amid safety concerns over the past 20 years, existing regulations face increasing scrutiny. This article initiates a scientific dialogue on improving regulations to balance consumer access with safety by focusing on premarket approval, label claims, current Good Manufacturing Practices, and adverse event reporting.

Wallace TC J Nutr, 2015. PMID 26063064

2015 / Conference summary / proceedings

An NIH conference identified key questions and challenges for primary care physicians regarding vitamin D testing, supplementation, and health risks.

In December 2014, the NIH Office of Dietary Supplements and co-sponsoring federal agencies held a conference titled 'Vitamin D: Moving Toward Evidence-based Decision Making in Primary Care.' More than 20 invited presenters and panelists evaluated laboratory measurement methods, clinical study evaluation, at-risk groups, patient values, and emerging data on the risks of excessive vitamin D intake. From these discussions and expert sources, eight key questions were developed to address conflicting evidence and guide primary care practice.

Taylor CL, Thomas PR, Aloia JF, et al. Am J Med, 2015. PMID 26071820

2015 / Narrative review

A review explores contradicting findings regarding the acute effects of chewing gum on cognitive performance, stress, and pain.

This review examines recent findings on the acute effects of chewing gum on cognitive performance, stress, and pain, noting that existing results are contradictory and replication has been challenging. The authors incorporate knowledge from studies on oral habits and bruxism to explore these discrepancies. They hypothesize that stress and cerebral functional specialization play major roles in the underlying physiological mechanisms.

Weijenberg RA, Lobbezoo F Biomed Res Int, 2015. PMID 26090381

2015 / Narrative review

Evidence suggests non-nutritive sweeteners have metabolic effects and may promote metabolic dysregulation through multiple mechanisms.

This review summarizes scientific evidence regarding potential mechanisms by which non-nutritive sweeteners (NNSs) might promote metabolic dysregulation. Epidemiological studies link NNS consumption, primarily from diet sodas, with increased risk for obesity, metabolic syndrome, and type 2 diabetes. Proposed mechanisms include interference with learned responses controlling glucose and energy homeostasis, disruption of gut microbiota inducing glucose intolerance, and interaction with sweet-taste receptors in the digestive tract. Laboratory findings also demonstrate an association between individual taste sensitivity to sucralose and acute metabolic responses to an oral glucose load.

Shows an association, not proof of cause and effect.

Pepino MY Physiol Behav, 2015. PMID 26095119

2015 / Narrative review

Fructose-containing caloric sweetener consumption is linked to weight gain, but evidence that excess intake is worse than other macronutrients is lacking.

This review synthesizes 10 years of research on fructose-containing caloric sweeteners (FCCS) and sugar-sweetened beverages (SSBs). Prospective cohort studies indicate that FCCS and SSB consumption is associated with weight gain over time. Ad libitum intervention studies show that increased FCCS generally increases total energy intake and body weight, while FCCS reduction decreases body weight gain; however, trials assessing SSB reduction alone fail to observe clinically significant weight loss. Scientific evidence that excess FCCS intake causes more deleterious health effects than an excess of other macronutrients is currently lacking.

Tappy L, Lê KA Curr Diab Rep, 2015. PMID 26104800

2015 / Narrative review

Cocoa flavanols are linked to improvements in endothelial function, blood pressure reduction, and potential cardiovascular benefits.

This review summarizes findings on cocoa's effects on blood pressure and cardiovascular health, focusing on putative mechanisms. Flavanols in cocoa are reported to exert favorable effects on endothelium-derived vasodilation by stimulating nitric oxide-synthase, increasing l-arginine availability, and decreasing NO degradation. Cocoa is also associated with reduced platelet aggregation, decreased lipid oxidation, improved insulin resistance, and blood pressure reductions. The authors note that long-term trials are still needed to determine if daily cocoa reduces blood pressure chronically and improves cardiovascular clinical outcomes.

Ferri C, Desideri G, Ferri L, et al. J Agric Food Chem, 2015. PMID 26125676

2015 / Systematic review

Limited trials show surrogate benefits from fasting, but clinical outcome data are scarce

A systematic review identified three randomized controlled clinical trials evaluating therapeutic fasting regimens on surrogate outcomes in humans, finding improvements in weight and other risk-related outcomes. In addition, two observational studies were identified in which fasting was associated with a lower prevalence of coronary artery disease or diabetes diagnosis. No randomized controlled trials of fasting for clinical outcomes were identified, and researchers concluded that substantial further human research is needed.

Horne BD, Muhlestein JB, Anderson JL Am J Clin Nutr, 2015. PMID 26135345

2015 / Narrative review

Star fruit toxicity in chronic kidney disease is linked to caramboxin inhibiting the GABAergic system, causing severe neurological effects.

This review examined publications from 2000 to 2014 regarding the mechanisms of star fruit (Averrhoa carambola) toxicity in individuals with chronic kidney disease. While past reports linked neurotoxicity to oxalate, recent findings indicate neurotoxic effects stem from caramboxin, which appears to inhibit the central nervous system's GABAergic system. Manifestations range from sobs and confusion to seizures and death. The authors emphasize the need for multidisciplinary efforts to alert chronic kidney disease patients about avoiding star fruit consumption.

de Oliveira ES, de Aguiar AS J Bras Nefrol, 2015. PMID 26154645

2015 / Narrative review / evidence summary

Diets rich in fruits, vegetables, and whole grains, and lower in red and processed meats, are linked to reduced risks of cancer and death.

This review summarizes evidence for the 4th edition of the European Code against Cancer regarding diet and cancer risk. Prospective studies indicate that dietary patterns high in fruits, vegetables, and whole-grain foods and low in red and processed meats and salt are linked to lower risks of cancer and mortality, and improved survival after breast and colorectal cancer diagnoses. Convincing evidence indicates dietary fiber protects against colorectal cancer, while red and processed meats increase its risk. High-calorie foods can promote obesity and increase cancer risk, and sugary drinks show some evidence of an association with pancreatic cancer.

Shows an association, not proof of cause and effect.

Norat T, Scoccianti C, Boutron-Ruault MC, et al. Cancer Epidemiol, 2015. PMID 26164653

2015 / Narrative evolutionary perspective review

An evolutionary perspective suggests humans adapted for moderate endurance activity, but natural selection also favored avoiding unnecessary exertion.

This perspective explores whether exercise is medicine and evaluates the paradox of why humans often avoid exercise despite its benefits. Evidence suggests humans evolved to be adapted for regular, moderate endurance activity into late age, yet were also selected to avoid unnecessary exertion because food energy was limited. Selection did not operate to cope with chronic inactivity, and trade-offs mean there is no evolutionary-determined optimal dose or type of physical activity for health. Consequently, promoting physical activity requires modifying environments to nudge or compel movement and make exercise fun.

Lieberman DE Curr Sports Med Rep, 2015. PMID 26166056

2015 / Narrative review

Evidence suggests calcium supplements lack cumulative bone density benefits and may carry risks that outweigh potential fracture reductions.

This review evaluates the benefits and risks of calcium supplementation in osteoporosis prevention. Most studies show little evidence linking calcium intake to bone density or bone loss, with re-analysis of the Auckland Calcium Study placebo group showing no relationship over 5 years across intakes of <400 to >1500 mg/day. Across meta-analyses, total fracture reductions range from 0-10% with no evidence for hip fracture prevention outside severe vitamin D deficiency, while five recent large studies failed to show fracture prevention in primary analyses. Conversely, supplements are associated with increased gastrointestinal side effects, a 17% increase in renal calculi, and a 20-40% increase in myocardial infarction risk.

Reid IR, Bristow SM, Bolland MJ J Intern Med, 2015. PMID 26174589